Herbcare

Herbcare Corporation is a pharmaceutical company headquartered in the Philippines that focuses on the development of clinically-validated herbal medicines. The company's primary focus is on metabolic disorders, specifically Type 2 Diabetes, through its flagship product Charantia (Momordica charantia). Unlike many nutraceutical firms, Herbcare has pursued a rigorous scientific approach, conducting clinical trials to demonstrate the efficacy of its lead candidate in blood glucose management. The company's operations encompass the entire value chain, from sourcing and extraction to manufacturing in GMP-certified facilities and international distribution. Herbcare's products are recognized by the medical community in Southeast Asia and are listed in professional pharmaceutical directories. The company continues to explore the therapeutic potential of indigenous plants through ongoing R&D and academic collaborations.